Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Attention Deficit Disorder with Hyperactivity | 22 | 2024 | 3708 | 1.960 |
Why?
|
| Depressive Disorder, Major | 14 | 2021 | 4762 | 1.550 |
Why?
|
| Bipolar Disorder | 15 | 2022 | 5092 | 1.330 |
Why?
|
| Methylphenidate | 4 | 2024 | 488 | 1.010 |
Why?
|
| Child of Impaired Parents | 3 | 2021 | 460 | 0.760 |
Why?
|
| Central Nervous System Stimulants | 4 | 2024 | 1177 | 0.620 |
Why?
|
| Panic Disorder | 1 | 2021 | 613 | 0.580 |
Why?
|
| Child Behavior Disorders | 2 | 2022 | 804 | 0.570 |
Why?
|
| Checklist | 5 | 2022 | 827 | 0.540 |
Why?
|
| Child Behavior | 4 | 2022 | 847 | 0.490 |
Why?
|
| Long QT Syndrome | 2 | 2017 | 467 | 0.470 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2017 | 489 | 0.460 |
Why?
|
| Adolescent Psychiatry | 3 | 2024 | 157 | 0.450 |
Why?
|
| Euphoria | 3 | 2018 | 65 | 0.440 |
Why?
|
| Methadone | 1 | 2015 | 321 | 0.420 |
Why?
|
| Adolescent | 41 | 2024 | 88326 | 0.410 |
Why?
|
| Child | 34 | 2024 | 80158 | 0.400 |
Why?
|
| Parents | 4 | 2022 | 3563 | 0.390 |
Why?
|
| Universities | 1 | 2017 | 993 | 0.380 |
Why?
|
| Child Psychiatry | 2 | 2024 | 228 | 0.370 |
Why?
|
| Stress Disorders, Post-Traumatic | 4 | 2018 | 4575 | 0.360 |
Why?
|
| Anxiety Disorders | 3 | 2021 | 2720 | 0.350 |
Why?
|
| Students | 2 | 2017 | 1741 | 0.340 |
Why?
|
| Adolescent Behavior | 1 | 2018 | 1190 | 0.340 |
Why?
|
| Depression | 5 | 2023 | 8126 | 0.330 |
Why?
|
| Aggression | 1 | 2014 | 750 | 0.320 |
Why?
|
| Psychiatric Status Rating Scales | 9 | 2022 | 6019 | 0.310 |
Why?
|
| Diffusion Tensor Imaging | 4 | 2024 | 2400 | 0.300 |
Why?
|
| Emotions | 2 | 2020 | 2739 | 0.290 |
Why?
|
| Suicide | 2 | 2017 | 1602 | 0.270 |
Why?
|
| Electrocardiography | 2 | 2017 | 6377 | 0.270 |
Why?
|
| Nerve Net | 5 | 2021 | 2291 | 0.270 |
Why?
|
| Cause of Death | 1 | 2017 | 3683 | 0.270 |
Why?
|
| Japan | 2 | 2023 | 1378 | 0.260 |
Why?
|
| Naltrexone | 2 | 2018 | 317 | 0.250 |
Why?
|
| Depressive Disorder | 3 | 2015 | 3728 | 0.250 |
Why?
|
| Antidepressive Agents | 2 | 2022 | 2897 | 0.230 |
Why?
|
| Students, Medical | 1 | 2017 | 1936 | 0.220 |
Why?
|
| Anisotropy | 3 | 2021 | 1283 | 0.210 |
Why?
|
| Pandemics | 1 | 2023 | 8656 | 0.210 |
Why?
|
| Child Development | 1 | 2014 | 2306 | 0.210 |
Why?
|
| Amphetamine | 1 | 2024 | 224 | 0.210 |
Why?
|
| Gyrus Cinguli | 2 | 2020 | 1115 | 0.200 |
Why?
|
| Humans | 54 | 2024 | 761596 | 0.200 |
Why?
|
| Comorbidity | 7 | 2024 | 10508 | 0.200 |
Why?
|
| Blood Pressure | 1 | 2017 | 8481 | 0.190 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2022 | 1390 | 0.180 |
Why?
|
| Male | 34 | 2023 | 360846 | 0.180 |
Why?
|
| Brain | 5 | 2021 | 27121 | 0.170 |
Why?
|
| Intention | 1 | 2023 | 347 | 0.170 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 3251 | 0.170 |
Why?
|
| Young Adult | 16 | 2022 | 59260 | 0.160 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2017 | 1988 | 0.160 |
Why?
|
| Female | 32 | 2023 | 392705 | 0.160 |
Why?
|
| Child, Preschool | 7 | 2022 | 42232 | 0.160 |
Why?
|
| Analgesics, Opioid | 1 | 2015 | 3808 | 0.160 |
Why?
|
| Veterans | 1 | 2013 | 2649 | 0.160 |
Why?
|
| Tetrahydrofolates | 1 | 2019 | 58 | 0.160 |
Why?
|
| Electronic Health Records | 1 | 2015 | 4811 | 0.150 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2021 | 306 | 0.150 |
Why?
|
| New Jersey | 1 | 2018 | 295 | 0.150 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2018 | 105 | 0.140 |
Why?
|
| Amygdala | 2 | 2015 | 1354 | 0.140 |
Why?
|
| Hypotension | 1 | 2023 | 879 | 0.140 |
Why?
|
| Infrared Rays | 1 | 2018 | 247 | 0.140 |
Why?
|
| Prevalence | 3 | 2020 | 15733 | 0.140 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2018 | 189 | 0.140 |
Why?
|
| Corpus Callosum | 2 | 2020 | 751 | 0.130 |
Why?
|
| Narcotic Antagonists | 2 | 2018 | 585 | 0.130 |
Why?
|
| Electroconvulsive Therapy | 1 | 2021 | 500 | 0.130 |
Why?
|
| Irritable Mood | 1 | 2017 | 194 | 0.130 |
Why?
|
| New York City | 1 | 2018 | 731 | 0.130 |
Why?
|
| Risk Factors | 11 | 2022 | 74213 | 0.130 |
Why?
|
| Cognition | 2 | 2024 | 6992 | 0.120 |
Why?
|
| Longitudinal Studies | 3 | 2022 | 14608 | 0.120 |
Why?
|
| Conditioning, Classical | 1 | 2017 | 368 | 0.110 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 588 | 0.110 |
Why?
|
| Prospective Studies | 6 | 2024 | 54423 | 0.110 |
Why?
|
| Extinction, Psychological | 1 | 2017 | 371 | 0.110 |
Why?
|
| Adult | 17 | 2024 | 221210 | 0.110 |
Why?
|
| Brain Injuries | 2 | 2015 | 2054 | 0.110 |
Why?
|
| Pilot Projects | 4 | 2022 | 8633 | 0.100 |
Why?
|
| Vietnam Conflict | 1 | 2013 | 100 | 0.100 |
Why?
|
| Educational Status | 2 | 2022 | 2522 | 0.100 |
Why?
|
| Self Report | 3 | 2021 | 3725 | 0.100 |
Why?
|
| Hospitals, General | 1 | 2015 | 798 | 0.090 |
Why?
|
| Affect | 2 | 2017 | 1486 | 0.090 |
Why?
|
| Treatment Outcome | 6 | 2024 | 64685 | 0.090 |
Why?
|
| Executive Function | 2 | 2019 | 1392 | 0.090 |
Why?
|
| Disease Progression | 2 | 2018 | 13510 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2015 | 2280 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2022 | 39106 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2021 | 36426 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 26129 | 0.080 |
Why?
|
| Cerebral Cortex | 2 | 2015 | 5779 | 0.080 |
Why?
|
| Antipsychotic Agents | 1 | 2022 | 3067 | 0.080 |
Why?
|
| Employment | 1 | 2015 | 1118 | 0.080 |
Why?
|
| Glutamic Acid | 1 | 2014 | 1176 | 0.080 |
Why?
|
| Photic Stimulation | 1 | 2015 | 1987 | 0.080 |
Why?
|
| Probability | 1 | 2014 | 2477 | 0.080 |
Why?
|
| Antimanic Agents | 2 | 2022 | 520 | 0.080 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 600 | 0.080 |
Why?
|
| Suicide, Attempted | 1 | 2017 | 1402 | 0.080 |
Why?
|
| Functional Laterality | 1 | 2015 | 2257 | 0.080 |
Why?
|
| Family Health | 1 | 2013 | 1257 | 0.080 |
Why?
|
| Massachusetts | 3 | 2017 | 8833 | 0.080 |
Why?
|
| Double-Blind Method | 5 | 2022 | 12341 | 0.080 |
Why?
|
| Fear | 1 | 2017 | 1477 | 0.070 |
Why?
|
| Athletes | 1 | 2015 | 1137 | 0.070 |
Why?
|
| Dietary Supplements | 2 | 2019 | 3415 | 0.070 |
Why?
|
| Motor Cortex | 1 | 2015 | 1007 | 0.070 |
Why?
|
| Visual Cortex | 1 | 2015 | 1108 | 0.070 |
Why?
|
| Resilience, Psychological | 1 | 2015 | 788 | 0.070 |
Why?
|
| Suicidal Ideation | 1 | 2017 | 1447 | 0.070 |
Why?
|
| Mood Disorders | 1 | 2013 | 1127 | 0.070 |
Why?
|
| Sex Factors | 2 | 2017 | 10554 | 0.060 |
Why?
|
| Sexual Behavior | 1 | 2015 | 2180 | 0.060 |
Why?
|
| Athletic Injuries | 1 | 2015 | 1216 | 0.060 |
Why?
|
| Delayed-Action Preparations | 2 | 2019 | 962 | 0.060 |
Why?
|
| Prefrontal Cortex | 1 | 2015 | 2220 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2014 | 3769 | 0.060 |
Why?
|
| Hippocampus | 1 | 2017 | 3766 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 12973 | 0.050 |
Why?
|
| Tic Disorders | 1 | 2024 | 136 | 0.050 |
Why?
|
| Personality Tests | 1 | 2022 | 81 | 0.050 |
Why?
|
| Psychopharmacology | 1 | 2024 | 148 | 0.050 |
Why?
|
| Quality of Life | 2 | 2022 | 13367 | 0.050 |
Why?
|
| Inositol | 1 | 2022 | 215 | 0.050 |
Why?
|
| ROC Curve | 2 | 2020 | 3578 | 0.050 |
Why?
|
| Acetylcysteine | 1 | 2022 | 260 | 0.050 |
Why?
|
| Anxiety | 1 | 2015 | 4573 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2015 | 6635 | 0.040 |
Why?
|
| Risk | 3 | 2016 | 9610 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2021 | 41495 | 0.040 |
Why?
|
| Folate Receptor 1 | 1 | 2019 | 40 | 0.040 |
Why?
|
| GTP Cyclohydrolase | 1 | 2019 | 47 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2015 | 4420 | 0.040 |
Why?
|
| Smoking | 1 | 2015 | 9053 | 0.040 |
Why?
|
| Drug Therapy, Combination | 2 | 2019 | 6312 | 0.040 |
Why?
|
| Middle Aged | 6 | 2021 | 220921 | 0.040 |
Why?
|
| Psychopathology | 1 | 2021 | 432 | 0.040 |
Why?
|
| Diet Therapy | 1 | 2019 | 151 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2024 | 1567 | 0.040 |
Why?
|
| Prognosis | 1 | 2018 | 29629 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2017 | 22176 | 0.040 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2019 | 297 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2020 | 2791 | 0.030 |
Why?
|
| Neuropsychological Tests | 2 | 2021 | 7054 | 0.030 |
Why?
|
| Time Factors | 1 | 2018 | 39969 | 0.030 |
Why?
|
| Rest | 1 | 2021 | 918 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2024 | 2767 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2017 | 23996 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2014 | 6845 | 0.030 |
Why?
|
| Medical History Taking | 1 | 2017 | 774 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 2395 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 11461 | 0.020 |
Why?
|
| Facial Expression | 1 | 2015 | 508 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2019 | 4021 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 2013 | 809 | 0.020 |
Why?
|
| United States | 2 | 2021 | 72340 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2021 | 3060 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2019 | 2118 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 4853 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2020 | 3600 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 10766 | 0.020 |
Why?
|
| Age Factors | 2 | 2013 | 18399 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6228 | 0.010 |
Why?
|
| Research Design | 1 | 2020 | 6180 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 2759 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 7828 | 0.010 |
Why?
|
| Mass Screening | 1 | 2013 | 5429 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 15266 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 20100 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 17904 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 80647 | 0.010 |
Why?
|
| Algorithms | 1 | 2013 | 14033 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 169310 | 0.000 |
Why?
|
Concepts
(177)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(43)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_